Skip to main content
SpringerLink
Log in

CASE REPORT: Post-Liver Transplant Crohn's Disease: Graft Tolerance but Not Self-Tolerance?

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Strober W, James SP: The immunologic basis of inflammatory bowel disease. J Clin Immunol 6:415–432, 1986

    Google Scholar 

  2. Macdonald TT, Murch SH: Aetiology and pathogenesis of chronic inflammatory bowel disease. Ballieres Clin Gastroenterol 8:1–34, 1994

    Google Scholar 

  3. Larusso NF, Wiesner RH, Ludwig J, MacCarty RL: Primary sclerosing cholangitis. N Engl J Med 310:899–903, 1984

    Google Scholar 

  4. Shaked A, Colonna JO, Goldstein A, Busuttil RW: The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 215:598–605, 1992

    Google Scholar 

  5. Stephens J, Goldstein R, Crippin J, et al: Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc 25:1122–1123, 1993

    Google Scholar 

  6. Riley TR. Schoen RE. Lee RG. Rakela J: A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol 92(2):279–282, 1997

    Google Scholar 

  7. Passfall J, Distler A, Riecken EO, Zeitz M: Development of ulcerative colitis under the immunosuppressive effect of cyclosporine. Clin Invest 70:611–613, 1992

    Google Scholar 

  8. Cuoco L, Tursi A, Cammarota G, Papa A, Fedeli G, Gasbarrini G: Onset of ulcerative colitis during immunosuppressive therapy for liver transplantation. Am J Gastroenterol 92(11):2134–2135, 1997

    Google Scholar 

  9. Lichtenstein GR: Medical therapies for inflammatory bowel disease. Opin Gastroenterol 9:588–599, 1993

    Google Scholar 

  10. Brynskov J, Freund L, Rasmussen SN, Lauritsen K, de Muckadell OS, Williams N, MacDonald AS, Tanton R, Molina F, Campanini MC: A placebo controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Eng J Med 321:845–850, 1989

    Google Scholar 

  11. Demetris AJ, Seaberg EC, Batts KP, Ferrell L, Ludwig J, Markin RS, Belle SH, Detre K: Reliability and predictive value of the NIDDK liver transplant database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 21:408–416, 1995

    Google Scholar 

  12. Knapp AB, Horst DA, Eliopoulos G, Gramm HF, Gaber LW, Falchuk KR, Falchuk ZM, Trey C: Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodefi-ciency syndrome. Gastroenterology 85:1399–1402, 1983

    Google Scholar 

  13. Wajsman R, Cappell MS, Biempica L, Cho KC: Terminal ileitis associated with cytomegalovirus and the acquired immunode-ficiency syndrome. Am J Gastroenterol 82:1264–1270, 1987

    Google Scholar 

  14. Sartor RB: Cyclosporine therapy for inflammatory bowel disease. N Engl J Med 330:1897–1898, 1994

    Google Scholar 

  15. Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K: Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 43(5):639–644, 1998

    Google Scholar 

  16. Bickston SJ. Cominelli F: Treatment of Crohn's disease at the turn of the century. N Engl J Med 339(6):401–402, 1998

    Google Scholar 

  17. Befeler AS, Lissoos TW, Schiano TD, Conjeevaram H, Dasgupta KA, Millis JM, Newell KA, Thisthlethwaite JR, Baker AL: Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 15:393–396, 1998

    Google Scholar 

  18. Sandborn WJ, Tremaine WJ: Cyclosporine treatment of inflammatory bowel disease. Mayo Clin Proc 67(10):981–990, 1992

    Google Scholar 

  19. Feagan BG, McDonald JW, Rochon J, Laupacis A, Fedorak KN, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R: Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial. N Engl J Med 330(26):1846–1851, 1994

    Google Scholar 

  20. Sandborn WJ: Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small-bowel and fistulizing Crohn's disease. Am J Gastroenterol 92:876–879, 1997

    Google Scholar 

  21. Fellermann K, Ludwig D, Stahl M, David-Walek T, Strange EF: Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506). Am J Gastroenterol 93:1860–1866, 1998

    Google Scholar 

  22. Lerardi E, Principi M, Francavilla R, Pisani A, Rendina M, Ingrosso M, Guglielmi FW, Panella C, Francavilla A: Oral tracrolimus long-term therapy in patients with Crohn's disease and steroid resistance. Aliment Pharmacol Ther 15:371–377, 2001

    Google Scholar 

  23. Brynskov J, Nielsen OH, Ahnfelt-Ronne I, Bendtzen K: Cytokines and their natural regulation in inflammatory bowel disease: A review. Dig Dis Sci 12:290–304, 1994

    Google Scholar 

  24. Neissner M, Volk BA: Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: Evaluation of in-vitro model. Eur J Clin Invest 25:155–164, 1995

    Google Scholar 

  25. Senju M, Hulstaert F, Lowder JR, et al: Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut 32:779–783, 1991

    Google Scholar 

  26. Targan S, Hanauer S, van Deventer SJH, et al: A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337:1029–1035, 1997

    Google Scholar 

  27. Neurath MF, Becker C, Barbulescu K: Role of NFκB in immune and inflammatory responses in the gut. Gut 43:856–860, 1998

    Google Scholar 

  28. Kam L, Targan SR: Cytokine-based therapies in inflammatory bowel disease. Curr Opin Gastroenterol 15:302–307, 1999

    Google Scholar 

  29. Hanauer SB: Inflammatory bowel disease. N Engl J Med 334:841–884, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of British Columbia and the British Columbia Transplant Society, Vancouver, British Columbia, Canada

    Alnoor Ramji, Siegfried R. Erb & Eric M. Yoshida

  2. Department of Anatomical Pathology, University of British Columbia and the British Columbia Transplant Society, Vancouver, British Columbia, Canada

    David A. Owen

  3. Department of Surgery, University of British Columbia and the British Columbia Transplant Society, Vancouver, British Columbia, Canada

    Charles H. Scudamore

Authors
  1. Alnoor Ramji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David A. Owen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Siegfried R. Erb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles H. Scudamore
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eric M. Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramji, A., Owen, D.A., Erb, S.R. et al. CASE REPORT: Post-Liver Transplant Crohn's Disease: Graft Tolerance but Not Self-Tolerance?. Dig Dis Sci 47, 522–527 (2002). https://doi.org/10.1023/A:1017951632444

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017951632444

Search

Navigation